Tomoaki Kato

Tomoaki Kato

Auto-generated profile, based on publicly available information

Tomoaki Kato

Columbia Center of Translational Immunology, Department of Medicine, Columbia University, New York, New York, USA; Department of Surgery, Columbia University/New York-Presbyterian Hospital, New York, New York, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
JFJianing Fu
Jianing Fu
JZJulien Zuber
Julien Zuber
BSBrittany Shonts
Brittany Shonts
AOAleksandar Obradovic
Aleksandar Obradovic
ZWZicheng Wang
Zicheng Wang
MSMegan Sykes
Megan Sykes
In humans receiving intestinal transplantation (ITx), long-term multilineage blood chimerism often develops. Donor T cell macrochimerism (≥4%) frequently occurs without graft-versus-host disease (GVHD) and is associated with reduced rejection. Here we demonstrate that patients with macrochimerism had high graft-versus-host (GvH) to host-versus-graft (HvG) T cell clonal ratios in their allografts. These GvH clones entered the circulation, where their peak levels were associated with declines in HvG clones early after transplant, suggesting that GvH reactions may contribute to chimerism and control HvG responses without causing GVHD. Consistently, donor-derived T cells, including GvH clones, and CD34+ hematopoietic stem and progenitor cells (HSPCs) were simultaneously detected in the recipients’ BM more than 100 days after transplant. Individual GvH clones appeared in ileal mucosa or PBMCs before detection in recipient BM, consistent with an intestinal mucosal origin, where donor GvH-reactive T cells expanded early upon entry of recipient APCs into the graft. These results, combined with cytotoxic single-cell transcriptional profiles of donor T cells in recipient BM, suggest that tissue-resident GvH-reactive donor T cells migrated into the recipient circulation and BM, where they destroyed recipient hematopoietic cells through cytolytic effector functions and promoted engraftment of graft-derived HSPCs that maintain chimerism. These mechanisms suggest an approach to achieving intestinal allograft tolerance.

21 August 2020 in Annals of Surgery
Verified
Journal Article
Closed access
TKTomoaki Md Kato
Tomoaki Md Kato
RHRegina Hwang
Regina Hwang
PLPeter Liou
Peter Liou
JWJoshua Weiner
Joshua Weiner
AGAdam Griesemer
Adam Griesemer
JEJean Emond
Jean Emond
Background and Aims: Ex vivo surgery may provide a chance at R0 resection for conventionally unresectable tumors. However, long-term outcomes have not been well documented. In this study, we analyze our 11-year outcomes to define its role. Study Design: We retrospectively analyzed 46 consecutive patients who underwent ex vivo surgery at our institution 2008–2019. Results: The types of tumors were: carcinoma (n = 20), sarcoma (n = 20) and benign to low grade tumor (n = 6). The type of ex vivo surgery was chosen based on tumor location and vascular involvement. The most commonly performed procedure was ex vivo hepatectomy (n = 18), followed by ex vivo resection and intestinal autotransplantation (n = 12), ex vivo Whipple procedure and liver autotransplantation (n = 8) and multivisceral ex vivo procedure (n = 7). Twenty-three patients (50%) are currently alive with median follow-up of 4.0-years (11 months–11.8 years). The overall survival was 70%/59%/52%, at 1-/3-/5-years, respectively. Patient survival for benign to low grade tumors, sarcoma, and carcinoma was 100%/100%/100%, 65%/60%/50%, and 65%/45%/40%, at 1-/3-/5-years, respectively. Ninety-one percent patients had R0 resection, and 57% had no recurrence to date with median follow-up of 3.1-years. Two patients (4.3%) died within 30 days due to sepsis and gastroduodenal artety (GDA) stump blowout. Two additional patients died between 30 and 90 days due to sepsis. Perioperative mortality in the last 23 consecutive cases was limited to 1 patient who died of sepsis between 30 and 90 days. Conclusions: For a selected group of patients with conventionally unresectable tumors, ex vivo surgery can offer effective surgical removal with a reasonably low perioperative mortality at experienced centers.

1 November 2018 in Journal of Hepatology
Verified
Journal Article
Closed access
RHRegina Hwang
Regina Hwang
PLPeter Liou
Peter Liou
TKTomoaki Kato
Tomoaki Kato

28 March 2016 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
JWJoshua Weiner
Joshua Weiner
AGAdam Griesemer
Adam Griesemer
EIEddie Island
Eddie Island
SLSteven Lobritto
Steven Lobritto
MMMercedes Martinez
Mercedes Martinez
TKTomoaki Kato
Tomoaki Kato

1 November 2003 in Pediatric and Developmental Pathology
Verified
Journal Article
Closed access
PDF file
PBPablo A. Bejarano
Pablo A. Bejarano
MSMaria F. Serrano
Maria F. Serrano
JCJavier Casillas
Javier Casillas
LDLouis P. Dehner
Louis P. Dehner
TKTomoaki Kato
Tomoaki Kato
ATAndreas Tzakis
Andreas Tzakis
A newborn female underwent a surgical resection for a hepatic mass discovered prenatally by ultrasonography, and diagnosed pathologically as a mesenchymal hamartoma. Within 4 months after surgery, multiple cutaneous hemangiomas developed and a multinodular mass was detected in the liver. A liver biopsy showed an infantile hemangioendothelioma with type I features. An orthotopic liver transplant was performed due to the extensive nature of the hepatic involvement and progressive respiratory compromise. Virtually the entire liver was involved by a large infantile hemangioendothelioma. A multicystic mesenchymal hamartoma was also found on the left side. In addition, the uninvolved hepatic parenchyma had features recapitulating the fetal liver. This simultaneous involvement of the liver by a mesenchymal hamartoma and infantile hemangioendothelioma is unique. A review of the literature revealed only one incompletely characterized case with similar findings.

1 October 2001 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
SDSpiros Delis
Spiros Delis
TKT. Kato
T. Kato
PRP. Ruiz
P. Ruiz
NMN. Mittal
N. Mittal
LBL. Babinski
L. Babinski
ATA. Tzakis
A. Tzakis